Endothelin inhibition improves cerebral blood flow and is neuroprotective in pneumococcal meningitis

Annals of Neurology

Volumn 47, Issue 3, 2000, Pages 329-335

  Pfister, Luz Andrea ^a   Tureen, Jay H ^b   Shaw, Sydney ^a   Christen, Stephan ^a   Ferriero, Donna M ^b   Täuber, Martin G ^a,b   Leib, Stephen L ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; CEFTRIAXONE; ENDOTHELIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL MENINGITIS; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN PROTECTION; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; BRAIN; CELL COUNT; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; FEMALE; MALE; MENINGITIS, PNEUMOCOCCAL; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; SULFONAMIDES;

EID: 0034009119     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200003)47:3<329::AID-ANA8>3.0.CO;2-R     Document Type: Article

References (37)

1. Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States to 1995. Active Surveillance Team. N Engl J Med 1997;337:970-976
2. Grimwood K, Anderson VA, Bond L, et al. Adverse outcomes of bacterial meningitis in school-age survivors. Pediatrics 1995; 95:646-656
3. Pfister HW, Koedel U, Haberl RL, et al. Microvascular changes during the early phase of experimental bacterial meningitis. J Cereb Blood Flow Metab 1990;10:914-922
4. Forderreuther S, Tatsch K, Einhaupl KM, Pfister HW. Abnormalities of cerebral blood flow in the acute phase of bacterial meningitis in adults. J Neurol 1992;239:431-436
5. Leib SL, Kim YS, Black SM, et al. Inducible nitric oxide synthase and the effect of aminoguanidine in experimental neonatal meningitis. J Infect Dis 1998;177:692-700
6. Odio CM, Faingezicht I, Paris M, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991;324:1525-1531
7. Goitein KJ, Tamir I. Cerebral perfusion pressure in central nervous system infections of infancy and childhood. J Pediatr 1983;103:40-43
8. Ashwal S, Stringer W, Tomasi L, et al. Cerebral blood flow and carbon dioxide reactivity in children with bacterial meningitis. J Pediatr 1990;117:523-530
9. Hardebo JE, Ka J, Owman C, Salford LG. Endothelin is a potent constrictor of human intracranial arteries and veins. Blood Vessels 1989;26:249-253
10. Adner M, Jansen I, Edvinsson L. Endothelin-A receptors mediate contraction in human cerebral, meningeal and temporal arteries. J Auton Nerv Syst 1994;49(Suppl):S117-S121
11. Inoue A, Yanagisawa M, Kimura S, et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989;86:2863-2867
12. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994;46:325-415
13. Arai H, Hori S, Aramori I, et al. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990;348: 730-732
14. Sakurai T, Yanagisawa M, Takuwa Y, et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990;348:732-735
15. Nilsson T, Cantera L, Adner M, Edvinsson L. Presence of contractile endothelin-A and dilatory endothelin-B receptors in human cerebral arteries. Neurosurgery 1997;40:346-351
16. Pierre LN, Davenport AP. Autoradiographic study of endothelin receptors in human cerebral arteries. J Cardiovasc Pharmacol 1995;26(Suppl 3):S326-S328
17. Willette RN, Zhang H, Mitchell MP, et al. Nonpeptide endothelin antagonist: cerebrovascular characterization and effects on delayed cerebral vasospasm. Stroke 1994;25:2450-2455
18. Koedel U, Gorriz C, Lorenzl S, Pfister HW. Increased endothelin levels in cerebrospinal fluid samples from adults with bacterial meningitis. Clin Infect Dis 1997;25:329-330
19. Ehrenreich H, Anderson RW, Fox CH, et al. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 1990;172:1741-1748
20. Corder R, Carrier M, Khan N, et al. Cytokine regulation of endothelin-1 release from bovine aortic endothelial cells. J Cardiovasc Pharmacol 1995;26(Suppl 3):S56-S58
21. Clozel M, Breu V, Gray GA, et al. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther 1994;270: 228-235
22. Leib SL, Kim YS, Chow LL, et al. Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci. J Clin Invest 1996;98:2632-2639
23. Li JS, Schurch W, Schiffrin EL. Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats [published erratum appears in Am J Hypertens 1996; 11:1144-1145]. Am J Hypertens 1996;9:803-811
24. Mulder P, Richard V, Derumeaux G, et al. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling. Circulation 1997;96:1976-1982
25. Teuscher AU, Lerch M, Shaw S, et al. Endothelin-1 infusion inhibits plasma insulin responsiveness in normal men. J Hypertens 1998;16:1279-1284
26. Heymann MA, Payne BD, Hoffman JIE, Rudolph AM. Blood flow measurements with radionuclide-labeled particles. Prog Cardiovasc Dis 1977;20:55-70
27. + when the Griess reaction is used to assay for nitrite. Anal Biochem 1995;224:502-508
28. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity: assessment of inflammation in rat and hamster models. Gastroenterology 1984;87:1344-1350
29. Bailey PJ, Fletcher DS. Arthus phenomenon. Methods Enzymol 1988;162:478-483
30. Koedel U, Lorenzl S, Gorriz C, et al. Endothelin B receptor-mediated increase of cerebral blood flow in experimental pneumococcal meningitis. J Cereb Blood Flow Metab 1998;18: 67-74
31. MacCumber MW, Ross CA, Snyder SH. Endothelin in brain: receptors, mitogenesis, and biosynthesis in glial cells. Proc Natl Acad Sci USA 1990;87:2359-2363
32. Bacic F, Uematsu S, McCarron RM, Spatz M. Secretion of immunoreactive endothelin-1 by capillary and microvascular endothelium of human brain. Neurochem Res 1992;17:699-702
33. Giaid A, Gibson SJ, Herrero MT, et al. Topographical localisation of endothelin mRNA and peptide immunoreactivity in neurones of the human brain. Histochemistry 1991;95:303-314
34. Hirata Y, Emori T, Eguchi S, et al. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 1993;91:1367-1373
35. Oda H, Murayama I, Nomura Y. Inhibition of inducible nitric oxide synthase expression by endothelin in rat glial cells prepared from the neonatal rat brain. J Neurochem 1997;69:669-674
36. Skopal J, Turbucz P, Vastag M, et al. Regulation of endothelin release from human brain microvessel endothelial cells. J Cardiovasc Pharmacol 1998;31 (Suppl 1):S370-S372
37. Bogdan I, Leib SL, Bergeron M, et al. Tumor necrosis factor-alpha contributes to apoptosis in hippocampal neurons during experimental group B streptococcal meningitis. J infect Dis 1997;176:693-697